Publications by authors named "Shun Manabe"

Claim this Profile
M
Middle cerebral artery aneurysms in older women with autosomal dominant polycystic kidney disease.
Hiroshi Kataoka, Shun Manabe, Yusuke Ushio, Hiroyuki Akagawa, Momoko Seki

Nephrol Dial Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attribute-Based Medicine for IgA Nephropathy: Risk Factor Constellations Influence Kidney Prognosis.
Hiroshi Kataoka, Shun Manabe, Takahito Moriyama, Yusuke Ushio, Kosaku Nitta

Nephrol Dial Transplant· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of plasmalemmal vesicle-associated protein-1 in patient with cyanotic nephropathy: a case report.
Yusuke Ushio, So Hirata, Shun Manabe, Mayuko Suyama, Ayano Tanaka

BMC Nephrol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease.
Kosaku Nitta, Hiroshi Kataoka, Shun Manabe, Shiho Makabe, Taro Akihisa

Clin Exp Nephrol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary casts containing crystals in light chain proximal tubulopathy.
Yusuke Ushio, Takashi Yokoyama, Shun Manabe, Momoko Seki, Yuki Kawaguchi

Kidney Int· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP).
Shinya Nakatani, Haruna Kawano, Mai Sato, Junichi Hoshino, Saori Nishio, Shun Manabe

Clin Exp Nephrol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD.
Taro Akihisa, Hiroshi Kataoka, Shiho Makabe, Shun Manabe, Rie Yoshida

Nephrol Dial Transplant· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease.
Yusuke Ushio, Hiroshi Kataoka, Hiroyuki Akagawa, Masayo Sato, Shun Manabe

J Nephrol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.
Hiroshi Kataoka, Yosuke Shimada, Tomonori Kimura, Saori Nishio, Shinya Nakatani, Shun Manabe

Clin Exp Nephrol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.
Hiroshi Kataoka, Yosuke Shimada, Tomonori Kimura, Saori Nishio, Shinya Nakatani, Shun Manabe

Clin Exp Nephrol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning for morbid glomerular hypertrophy.
Yusuke Ushio, Hiroshi Kataoka, Kazuhiro Iwadoh, Mamiko Ohara, Tomo Suzuki, Shun Manabe

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Akinari Sekine, Sumi Hidaka, Tomofumi Moriyama, Yasuto Shikida, Keiji Shimazu, Shun Manabe

J Clin Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease.
Hiroshi Kataoka, Hiroyuki Akagawa, Rie Yoshida, Naomi Iwasa, Yusuke Ushio, Shun Manabe

Sci Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease.
Taro Akihisa, Hiroshi Kataoka, Shiho Makabe, Shun Manabe, Rie Yoshida

Clin Exp Nephrol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen Staining.
Masayo Sato, Shun Manabe, Mitsuyo Itabashi, Shigeru Horita, Orie Hirose

Intern Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Mutations for Kidney Volume in ADPKD.
Hiroshi Kataoka, Rie Yoshida, Naomi Iwasa, Masayo Sato, Shun Manabe

Kidney Int Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Pleiotropic effect of erythropoiesis‑stimulating agents on circulating endothelial progenitor cells in dialysis patients.
Takashi Naito, Shun Manabe, Hideki Nishimura, Tomoki Gibo, Mai Tosaka

Clin Exp Nephrol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleiotropic effect of erythropoiesis-stimulating agents on circulating endothelial progenitor cells in dialysis patients.
Takashi Naito, Manabe Shun, Hideki Nishimura, Tomoki Gibo, Mai Tosaka

Clin Exp Nephrol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Pleiotropic effect of erythropoiesis‑stimulating agents on circulating endothelial progenitor cells in dialysis patients.
Takashi Naito, Manabe Shun, Hideki Nishimura, Tomoki Gibo, Mai Tosaka

Clin Exp Nephrol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD.
Shiho Makabe, Shun Manabe, Hiroshi Kataoka, Taro Akihisa, Rie Yoshida

Kidney Int Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal amyloidosis with monotypic IgM lambda deposition.
Shun Manabe, Masayo Sato, Hiroshi Kataoka, Toshio Mochizuki, Kosaku Nitta

Kidney Int· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease.
Taro Akihisa, Shun Manabe, Hiroshi Kataoka, Shiho Makabe, Rie Yoshida

Kidney360· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease.
Hiroshi Kataoka, Saki Watanabe, Masayo Sato, Shun Manabe, Shiho Makabe

Hepatol Int· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The origin of urinary mulberry cells in Fabry disease.
Takashi Yokoyama, Shun Manabe, Shigeru Horita, Hiroshi Kataoka, Toshio Mochizuki

Kidney Int· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lupus Nephritis and Hydroxychloroquine-Associated Zebra Bodies: Not Just in Fabry Disease.
Shun Manabe, Toshio Mochizuki, Masayo Sato, Hiroshi Kataoka, Sekiko Taneda

Kidney Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis